Strand Life Sciences marks a significant milestone in our 24-year journey with the inauguration of it’s new Genomic Diagnostics and Research Centre in Bengaluru. This new facility, equipped with cutting-edge sequencing technologies, aims to advance diagnostic solutions and life-saving cancer research. This special occasion also witnessed the launch of CancerSpot—a groundbreaking blood test for the early detection of multiple cancers. Utilizing advanced methylation profiling technology, CancerSpot identifies tumor DNA fragments in blood samples, offering a simple, non-invasive method for cancer screening. The test is designed with robust signatures from Indian cohorts, ensuring global applicability

Strand Life Sciences is a renowned global genomics and bioinformatics software and services leader with a primary goal to make precision medicine accessible to everyone.